首页 > 市场调查报告书 > 医疗设备

生技设备 3D列印

市场调查报告书

商品编码

1618309

Bioink 市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Bioink Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月04日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球生物墨水市场价值为7,040 万美元，预计2024 年至2032 年复合年增长率为12.5%。率上升所推动。对生物列印组织和器官等创新医疗解决方案的需求不断增长，正在推动市场扩张。 3D 生物列印技术的进步以及製药公司和研究机构之间合作的加强也有助于市场成长。这些合作关係有助于推动生物墨水配方的创新，并增强其在组织工程和药物传输等领域的应用。

生物列印系统的不断发展以及生物相容性和多功能性生物墨水的开发预计将进一步加速市场成长。市场根据生物墨水类型分为天然和合成类别。 2023年，天然生物墨水领域以6,070万美元的收入引领市场。天然生物墨水因其生物相容性和无毒特性而受到青睐，使其适合组织工程应用。

生物医学研究中对永续实践的日益重视进一步增加了对天然生物墨水的需求，因为它们通常来自可再生和可生物降解的来源。从材料来看，生物墨水市场包括胶原蛋白、海藻酸盐、明胶、琼脂糖、壳聚醣、Pluronic等。胶原蛋白成为主导材料，到 2023 年将占据 36% 的市场份额。胶原蛋白在伤口癒合和组织修復等各种医疗应用中的使用，再加上监管部门的批准，预计将推动该领域的持续成长。。此外，北美受益于鼓励对生物列印技术投资的支持性监管环境，促进了市场的进一步成长。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	7040 万美元
预测值	2.021 亿美元
复合年增长率	12.5%

产业生态系统分析
产业影响力
- 成长动力
  - 再生医学中的应用不断增加
  - 对 3D 列印组织和器官的需求增加
  - 慢性病和器官衰竭盛行率上升
  - 生物列印技术的进步
- 产业陷阱与挑战
  - 严格的审批备案流程
  - 製造成本高
成长潜力分析
监管环境
未来市场趋势
技术进步
差距分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

主要趋势
天然生物墨水
合成生物墨水

第 6 章：市场估计与预测：按材料划分，2021 - 2032 年

主要趋势
胶原
海藻酸盐
明胶
琼脂糖
壳聚醣
普鲁罗尼克
其他材料

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
组织工程
医疗应用
药物发现与递送
其他应用

第 8 章：市场估计与预测：按印刷方式，2021 - 2032 年

主要趋势
基于挤压的生物列印
基于喷墨的生物列印
基于雷射的生物列印

第 9 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
製药和生物技术公司
学术及研究机构
医院和诊所
其他最终用途

第 10 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 11 章：公司简介

Allevi, Inc. (3D Systems)
Axolotl Biosciences
BIO INX
CELLLINK (BICO)
CollPlant Biotechnologies Ltd
Foldink
Gelomics
INNOREGEN, Inc.
Merck KGaA
Rokit Healthcare
TheWell Bioscience Inc.
UPM Biomedicals
Viscient Biosciences
VoxCell BioInnovation Inc.

简介目录

Product Code: 9118

The Global Bioink Market was valued at USD 70.4 million in 2023 and is projected to grow at a CAGR of 12.5% from 2024 to 2032. This rapid growth is primarily driven by the increasing use of bioink in biomedical research therapy and the rising prevalence of chronic diseases and organ failure. The growing demand for innovative medical solutions, such as bio-printed tissues and organs, is fueling the market expansion. Advancements in 3D bioprinting technology, alongside increased collaborations between pharmaceutical companies and research institutions, also contribute to market growth. These partnerships help drive innovations in bioink formulations, enhancing their application in areas like tissue engineering and drug delivery.

The continuous evolution of bioprinting systems and the development of bioinks that are both biocompatible and versatile are expected to further accelerate market growth. The market is segmented based on bioink types into natural and synthetic categories. In 2023, the natural bioink segment led the market with a revenue of USD 60.7 million. Natural bioinks are favored due to their biocompatibility and non-toxic properties, making them suitable for tissue engineering applications.

The increasing emphasis on sustainable practices in biomedical research has further bolstered the demand for natural bioinks, as they are often derived from renewable and biodegradable sources. In terms of materials, the bioink market includes collagen, alginate, gelatin, agarose, chitosan, Pluronic, and others. Collagen emerged as the dominant material, holding a 36% market share in 2023. Its high compatibility with human tissue and its ability to form fibrous networks make collagen essential for tissue engineering and regenerative medicine. The use of collagen in various medical applications, such as wound healing and tissue repair, coupled with regulatory approvals, is expected to drive continued growth in this segment.Regionally, North America accounted for a significant 43.6% of the market in 2023. The availability of advanced bioink technologies, including improved printing resolutions and multi-material capabilities, enhances the adoption of bioink-based products in the region. Furthermore, North America benefits from a supportive regulatory environment encouraging investment in bioprinting technology, fostering further market growth.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$70.4 Million
Forecast Value	$202.1 Million
CAGR	12.5%

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising application in regenerative medicine
  - 3.2.1.2 Increase in demand for 3D printed tissue and organs
  - 3.2.1.3 Rise in prevalence of chronic disease and organ failure
  - 3.2.1.4 Advancement in bioprinting technologies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent approval filing process
  - 3.2.2.2 High manufacturing cost
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Technological advancements
3.7 GAP analysis
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Natural bioink
5.3 Synthetic bioink

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Collagen
6.3 Alginate
6.4 Gelatin
6.5 Agarose
6.6 Chitosan
6.7 Pluronic
6.8 Other materials

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Tissue engineering
7.3 Medical application
7.4 Drug discovery & delivery
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Printing Modality, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Extrusion based bioprinting
8.3 Ink-jet based bioprinting
8.4 Laser-based bioprinting

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Pharmaceutical & biotechnology companies
9.3 Academic & research institutes
9.4 Hospitals and clinics
9.5 Other End Use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.1.1 U.S.
- 10.1.2 Canada
10.2 Europe
- 10.2.1 Germany
- 10.2.2 UK
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 Australia
- 10.3.5 South Korea
- 10.3.6 Rest of Asia Pacific
10.4 Latin America
- 10.4.1 Brazil
- 10.4.2 Mexico
- 10.4.3 Rest of Latin America
10.5 Middle East and Africa
- 10.5.1 South Africa
- 10.5.2 Saudi Arabia
- 10.5.3 UAE
- 10.5.4 Rest of Middle East and Africa